Chemical genetic strategy for targeting protein kinases based on covalent complementarity.
Garske, A.L., Peters, U., Cortesi, A.T., Perez, J.L., Shokat, K.M.(2011) Proc Natl Acad Sci U S A 108: 15046-15052
- PubMed: 21852571 
- DOI: 10.1073/pnas.1111239108
- Primary Citation of Related Structures:  
3SVV - PubMed Abstract: 
The conserved nature of the ATP-binding site of the > 500 human kinases renders the development of specific inhibitors a challenging task. A widely used chemical genetic strategy to overcome the specificity challenge exploits a large-to-small mutation of the gatekeeper residue (a conserved hydrophobic amino acid) and the use of a bulky inhibitor to achieve specificity via shape complementarity ...